DSIJ Mindshare

Lira, the currency of Turkey, has fallen by 40 per cent the year till date with a fear of contagion being spread to other emerging countries including India.

 The company has an order book of more than Rs. 80,000 crore in hand. This leads to book/bill ratio of 13x which is highest amongst infrastructure companies.

The stock of pharma major Dr. Reddy's Laboratories was buzzing on Thursday as market expected the company to receive US drug regulator's approval for blockbuster cancer drug imatinib mesylate.

Sun Pharmaceutical Industries Limited has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the US Food and Drug Administration (FDA). CEQUA is indicated to increase the tear production in patients that suffer from the condition of Keratoconjunctivitis sicca that is, dry eyes.

Road and infrastructure builder, KNR Construction may sell four of its HAM (Hybrid Annuity Model) projects, reported a leading business daily. The company is said to be in talks with private equity firm Brookfield and Cube Highway for the deal.